Next generation sequencing-based gene panel tests for the management of solid tumors

Area of Science:

• Genomic Medicine
• Oncology
• Molecular Diagnostics

Background:

• Next generation sequencing (NGS) is crucial for integrating genomic data into clinical settings.
• Gene panel tests utilizing targeted sequences offer practical diagnostic solutions for personalized cancer care.
• Understanding genetic variations is key to predicting patient response to therapies.

Purpose of the Study:

• To review the concept of precision cancer medicine driven by NGS gene panel testing.
• To emphasize the importance of sample quality control in routine genomic diagnostics.
• To explore geographic and ethnic variations in cancer genomes and future research directions.

Main Methods:

• Review of current literature and clinical applications of NGS-based gene panel testing.
• Discussion of the clinical utility of gene panels for therapy response prediction.
• Analysis of factors influencing genomic testing, including sample quality and population genetics.

Main Results:

• NGS gene panel tests are effective tools for individualized cancer patient care.
• Clinical utility spans identifying genetic drivers of therapy response, microsatellite instability, and DNA repair deficiencies.
• Geographic and ethnic differences in cancer genomes present unique challenges and opportunities.

Conclusions:

• Precision cancer medicine relies heavily on the effective implementation of NGS gene panel tests.
• Rigorous sample quality control is essential for reliable genomic testing results.
• Further research is needed to address population-specific genomic variations for equitable cancer treatment.